Collaborations & PartnershipsNF1Outside Opportunities Funding Opportunity: 2025 Francis S. Collins Scholars
Collaborations & PartnershipsNF2-SWNPress ReleasePublicationsScience & ResearchTop StoryTop Story EU Brigatinib Shows Promise for NF2-SWN: A Direct Result of CTF’s Synodos Initiative
Collaborations & PartnershipsNF1Outside Opportunities Funding Opportunity: Developmental and Hyperactive Ras Tumor (DHART) SPORE Program
Awards & GrantsCollaborations & PartnershipsFeaturedFeatured EUScience & Research CTF Featured at American Society of Gene & Cell Therapy Annual Meeting
Collaborations & PartnershipsFeaturedFeatured EUPress ReleaseScience & ResearchSWN Revolutionary Partnership Drives Breakthrough Research Investigation into Schwannomatosis
Collaborations & PartnershipsFeaturedFeatured EUGlobalNF1Press Release Healx to receive investment from Children’s Tumor Foundation to advance Neurofibromatosis Type 1 treatments
Collaborations & PartnershipsScience & Research Schwannomatosis Open Research Collaborative Computational Partnership Initiative
Collaborations & PartnershipsScience & Research Chan Zuckerberg Initiative’s Science in Society Program announced a Request for Applications
Collaborations & PartnershipsNF1Press ReleaseScience & Research SpringWorks Therapeutics Announces Positive Topline Results from the Phase 2b ReNeu Trial of Mirdametinib in NF1-PN
